Dengue in Peru: DENV-3 Serotype

November 29, 2024

Health authorities in Peru (CDC Peru) have issued an epidemiological alert due to a nationwide increase in dengue cases, linked to factors such as climate variability and the circulation of the DENV-3 serotype.

This situation poses a risk to the population, especially in regions experiencing active outbreaks and sustained virus transmission.

As of epidemiological week (EW) 46 in 2024, a total of 273,847 dengue cases have been reported nationwide, representing a 10.1% increase compared to the previous year.

Of these cases, 90.29% are dengue without warning signs, 9.44% are cases with warning signs, and 0.27% are severe dengue, with a national cumulative incidence rate of 802.81 cases per 100,000 inhabitants. Additionally, 259 deaths have been reported, 252 of which are directly attributed to dengue.

Since EW 40, a rising trend in dengue cases has been observed.

The departments currently experiencing this increase include Loreto, San Martín, Piura, Tumbes, Ucayali, Huánuco, Junín, Cusco, Cajamarca, Madre de Dios, Pasco, Amazonas, and Ayacucho.

In EW 46, 31 districts are in an outbreak situation: Yurimaguas, Lagunas, Requena, Barranca, Belén (Loreto), Moyobamba, Tarapoto, Juanjui, Pachiza, Pardo Miguel, Morales, Nuevo Progreso, Pólvora, and Tocache (San Martín); Castilla, Paita, Piura, Sullana, Pariñas, and Chulucanas (Piura); Tumbes (Tumbes); Chanchamayo, San Ramón, and Pangoa (Junín); Callería and Padre Abad (Ucayali); Rupa Rupa and Codo del Pozuzo (Huánuco); Tambopata (Madre de Dios); Jaén (Cajamarca); and Nieva (Amazonas).

Furthermore, 52 districts report active transmission, and 68 districts remain at a plateau phase.

Recommendations have been issued to implement and manage comprehensive measures aimed at controlling, treating, and monitoring dengue patients promptly.

More information for traveling to Peru

Share on social

Facebook
Twitter
LinkedIn